MEDINCELL SA (MEDCL.PA) Stock Earnings Estimates
Europe • Euronext Paris • EPA:MEDCL • FR0004065605
22.56 EUR
-0.52 (-2.25%)
Last: Jan 30, 2026, 05:29 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.889M 141.78% | 9.032M -8.67% | 25.419M 181.43% | 34.304M 34.95% | 72.594M 111.62% | 142.67M 96.53% | 187.58M 31.48% | 161.57M -13.87% | 156.39M -3.21% | 254.78M 62.91% | 189.53M -25.61% | |
| EBITDA YoY % growth | -22.387M -0.40% | -19.125M 14.57% | -8.751M 54.24% | -5.485M 37.32% | 40.191M 832.78% | 66.487M 65.43% | 113.89M 71.30% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -24.052M -1.00% | -20.844M 13.34% | -10.741M 48.47% | -5.103M 52.49% | 40.756M 898.64% | 94.825M 132.67% | 112.92M 19.08% | 107.67M -4.65% | 101.58M -5.66% | 196.04M 92.99% | 130.02M -33.68% | |
| Operating Margin | -243.22% | -230.78% | -42.26% | -14.88% | 56.14% | 66.46% | 60.20% | 66.64% | 64.95% | 76.94% | 68.60% | |
| EPS YoY % growth | N/A -46.42% | N/A -13.12% | N/A 20.47% | -0.31 59.91% | 0.59 291.60% | 0.94 60.53% | 2.99 217.66% | 4.26 42.16% | 4.47 5.01% | 8.47 89.54% | 5.74 -32.25% |
All data in EUR
| Q4 / 26 | |
|---|---|
| EPS Q2Q % growth | 0.02 111.88% |
| Revenue Q2Q % growth | 16.907M 0.64% |
| EBITDA Q2Q % growth | 100.00% |
| EBIT Q2Q % growth | -2.715M 15.47% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2026 Q2Q % growth | -0.51 | -0.28 | -0.23 | -83.39% |
| Q4 2025 Q2Q % growth | -0.13 77.59% | -0.43 | 0.30 | 69.95% |
| Q4 2024 Q2Q % growth | -0.58 | -0.33 | -0.25 | -75.97% |
| Q1 2022 Q2Q % growth | -152.63% | -0.74 | % | |
| Q1 2021 Q2Q % growth | 64.60% | -0.29 | % |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2026 Q2Q % growth | 11.608M 34.66% | 8.697M | 2.911M | 33.47% |
| Q4 2025 Q2Q % growth | 16.799M 720.66% | 4.223M | 12.576M | 297.80% |
| Q2 2025 Q2Q % growth | 8.62M 23.41% | % | ||
| Q4 2024 Q2Q % growth | 2.047M -46.97% | 8.24M | -6.193M | -75.16% |
| Q2 2024 Q2Q % growth | 6.985M 15.84% | % | ||
| Q4 2023 Q2Q % growth | 3.86M 55.02% | % | ||
| Q2 2023 Q2Q % growth | 6.03M 276.88% | % | ||
| Q4 2022 Q2Q % growth | 2.49M -64.22% | % | ||
| Q2 2022 Q2Q % growth | 1.6M 30.08% | % | ||
| Q1 2022 Q2Q % growth | -41.44% | 11.828M | % | |
| Q4 2021 Q2Q % growth | 6.96M 673.33% | % | ||
| Q2 2021 Q2Q % growth | 1.23M -37.24% | % | ||
| Q1 2021 Q2Q % growth | 265.70% | 20.198M | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | -1.28% | -120.37% |
| Revenue | N/A | N/A | 0% | 0.65% |